b'Gel and CapillaryAssays and Assays82 FLT3 Mutation Assay90 LeukoStrat CDx FLT3 MutationGel Detection Assay - AUS84 FLT3 Mutation Assay 2.0 92 LeukoStrat CDx FLT3 MutationABI Fluorescence DetectionAssay - Japan 86 LeukoStrat CDx FLT3 MutationAssay (IVD) - USA 88 LeukoStrat CDx FLT3 MutationAssay (CE-marked) WARRANTY AND LIABILITYInvivoscribe, Inc. (Invivoscribe) is committed to providing the highest quality products. Invivoscribe warrants that the products meet or exceed the performance standards described in the Instructions For Use, as to products with such an insert. If a product is covered by product specifications and does not perform as specified, our policy is to replace the product or credit the full purchase price. No other warranties of any kind, expressed or implied, are provided by Invivoscribe. Invivoscribe liability shall not exceed the purchase price of the product. Invivoscribe shall have no liability for direct, indirect, consequential or incidental damages arising from the use, results of use, or inability to use its products; product efficacy under purchaser controlled conditions in purchasers laboratory must be established and continually monitored through purchaser defined and controlled processes including but not limited to testing of positive, negative, and blank controls every time a sample is tested. Ordering, acceptance, and use of product constitutes purchaser acceptance of sole responsibility for assuring product efficacy and purchaser agreement to the limitation of liability set forth in this paragraph.NOTICE: The products in the section that follows are in vitro diagnostic products and are not available for sale or use within North America.These products require nucleic acid amplification methods such as Polymerase Chain Reaction (PCR). No license under these patents to use amplification processes or enzymes is conveyed expressly or by implication to the purchaser by the purchase of these products. LeukoStrat is a registered trademark of Invivoscribe.'